Browse Title Index
| Issue | Title | |
| Vol 8, No 4 (2017) | Minimal residual disease assessment in plasma cell myeloma patients in Poland: survey of the Polish Myeloma Consortium | Abstract PDF (Polish) |
| Agnieszka Krzywdzińska, Iwona Solarska, Bartosz Puła, Anna Czyż, Dominik Dytfeld, Artur Jurczyszyn, Krzysztof Giannopoulos, Agnieszka Balana-Nowak, Paulina Własiuk, Anna Waszczuk-Gajda, Maria Król, Marek Dudziński, Adrian Burdacki, Tomasz Wróbel, Donata Szymczak, Olga Jankowska-Łęcka, Paweł Bernatowicz, Jan Zaucha, Agata Tyczyńska, Agnieszka Druzd-Sitek, Piotr Centkowski, Alina Świderska, Rutkowska Elżbieta, Krzysztof Lewandowski, Krzysztof Warzocha, Krzysztof Jamroziak | ||
| Vol 8, No 3 (2017) | Minimal residual disease testing for multiple myeloma | Abstract PDF HTML |
| Beatriz Sanchez-Vega, Rosa Ayala, Teresa Cedena, Joaquin Martinez-Lopez | ||
| Vol 5, No 2 (2014) | Molecular background and therapeutic perspectives of acute lymphoblastic leukemia BCR-ABL1-like | Abstract PDF (Polish) HTML (Polish) |
| Joanna Madzio, Agata Pastorczak, Wojciech Młynarski | ||
| Vol 3, No 4 (2012) | Molecular mechanisms and pathogenetic role of BCL6 deregulation in diffuse large B-cell lymphomas — clinical and therapeutic implications | Abstract PDF (Polish) |
| Weronika Prusisz, Tomasz Sewastianik, Przemysław Juszczyński | ||
| Vol 4, No 4 (2013) | Molecular oncogenic defects in subtypes of diffuse large B-cell lymphoma | Abstract PDF (Polish) HTML (Polish) |
| Marta Bielska, Ewa Lech-Marańda, Agata Pastorczak, Wojciech Młynarski | ||
| Vol 7, No 4 (2016) | Molecular pathogenesis of chronic lymphocytic leukemia | Abstract PDF (Polish) |
| Emilia Białopiorowicz, Przemysław Juszczyński | ||
| Vol 1, No 4 (2010) | Monoclonal antibodies anti-CD20 in the therapy of aggressive lymphomas | Abstract PDF (Polish) |
| Tomasz Wróbel | ||
| Vol 7, No 2 (2016) | Morbidity and mortality of patients with chronic lymphocytic leukemia in Poland between 1999 and 2013 | Abstract PDF (Polish) HTML (Polish) |
| Joanna Didkowska, Urszula Wojciechowska, Jakub Gierczyński, Krzysztof Warzocha, Ewa Lech-Marańda | ||
| Vol 1, No 3 (2010) | Myelodysplastic/myeloproliferative neoplasms - recent advances and diagnostic issues | Abstract PDF (Polish) |
| Monika Prochorec-Sobieszek | ||
| Vol 6, No 1 (2015) | Myeloproliferative neoplasms and myelodysplastic syndromes — advances in diagnosis and therapy | Abstract PDF (Polish) HTML (Polish) |
| Joanna Góra-Tybor | ||
| Vol 12, Supp. A (2021) | Nadciśnienie tętnicze i inne działania niepożądane terapii ponatynibem w układzie sercowo-naczyniowym u 60-letniego chorego na przewlekłą białaczkę szpikową | Abstract PDF (Polish) |
| Elżbieta Szczepanek, Tomasz Sacha | ||
| Vol 3, No 2 (2012) | Najważniejsze doniesienia z VI Ogólnopolskiej Konferencji po-ASH (American Society of Hematology) | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 1, No 1 (2010) | Nasal T/NK-cell lymphoma - case report | Abstract PDF (Polish) |
| Ewa Kalinka-Warzocha, Krzysztof Warzocha | ||
| Vol 4, No 3 (2013) | National Institute of Oncology and Hematology | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Warzocha | ||
| Vol 6, No 4 (2015) | National Institute of Oncology and Hematology — to be or not to be? | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 5, No 1 (2014) | National oncology network | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Warzocha | ||
| Vol 6, No 3 (2015) | New perspectives for antithrombotic therapy — coagulation factor XI as a target | Abstract PDF (Polish) HTML (Polish) |
| Jacek Treliński | ||
| Vol 8, No 4 (2017) | New prognostic factors in primary myelofibrosis — a current state of knowledge | Abstract PDF (Polish) |
| Marta Anna Sobas, Tomasz Wróbel | ||
| Vol 6, No 1 (2015) | New therapeutic targets in lymphoid malignancies — 5-year research perspective | Abstract PDF (Polish) HTML (Polish) |
| Przemysław Juszczyński | ||
| Vol 4, Supp. B (2013) | Nilotinib in patients with chronic myelogenous leukemia with hepatotoxicity after imatinib | Abstract PDF (Polish) |
| Rafał Becht | ||
| Vol 2, Supp. B (2011) | Nilotinib induced complete molecular response in the patient in chronic phase of chronic myeloid leukemia and imatinib intolerance after acetaminophen intake | Abstract PDF (Polish) |
| Maria Lewandowska, Michał Gniot, Krzysztof Lewandowski | ||
| Vol 9, Supp. A (2018) | Nilotinib treatment of a patient with chronic myelogenous leukemia after previous failure to imatinib and dasatinib | Abstract PDF (Polish) |
| Marzena Wątek, Ewa Wasińska, Sylwia Kościołek-Zgódka, Marcin Pasiarski, Stanisław Góźdź | ||
| Vol 3, No 4 (2012) | Non-Hodgkin lymphoma in locoregional lymph nodes in a patient with breast cancer | Abstract PDF (Polish) |
| Ewa Kalinka-Warzocha, Maja Wasylecka-Morawiec, Dorota Jesionek-Kupnicka, Agnieszka Kołacińska | ||
| Vol 9, No 3 (2018) | Novel diagnostic pathways in cardiac amyloidosis. Case-series study on transthyretin amyloidosis. | Abstract PDF (Polish) |
| Paweł Rubiś, Ewa Dziewięcka, Katarzyna Holcman, Wojciech Szot, Sylwia Wiśniowska-Śmiałek, Agata Leśniak-Sobelga, Marta Hlawaty, Piotr Podolec, Magdalena Kostkiewicz | ||
| Vol 6, No 3 (2015) | Novel insight into paroxysmal nocturnal hemoglobinuria | Abstract PDF (Polish) HTML (Polish) |
| Agnieszka Piekarska, Justyna Spychalska | ||
| 251 - 275 of 543 Items | << < 6 7 8 9 10 11 12 13 14 15 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
